HSIC stock forecast
Our latest prediction for Henry Schein, Inc.'s stock price was made on the Nov. 7, 2019 when the stock price was at 68.74$.
In the short term (2weeks), HSIC's stock price should outperform the market by 0.06%. During that period the price should oscillate between -3.21% and +3.25%.
In the medium term (3months), HSIC's stock price should outperform the market by 0.09%. During that period the price should oscillate between -7.65% and +9.32%.Get email alerts
About Henry Schein, Inc.
Henry Schein, Inc. engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. It operates through the Healthcare Distribution, and Technology and Value-Added Services segments. The Healthcare Distribution segment includes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins. The Technology & Value-Added Services segment offers financial services on a non-recourse basis, e-services practice, technology, network and hardware services. The company was founded by Henry Schein and Esther Schein in 1932 and is headquartered in Melville, NY.
At the moment the company generates 13574M USD in revenues.
On its last earning announcement, the company reported a profit of 3.30$ per share.
The book value per share is 19.03$
Three months stock forecastNov. 7, 2019
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|